| http://www.w3.org/ns/prov#value | - Novartis Presents Addl Data From Once-daily COPD Clinical Trial Programs 9/3/2012 1:49 AM ET Novartis (NVS: Quote) presented additional data from its once-daily chronic obstructive pulmonary disease or COPD clinical trial programs at the European Respiratory Society or ERS Congress.Novartis said that overall, it presented 14 abstracts, including data from the investigational QVA149 (fixed-dose com
|
